$30.110
+0.039 (+0.13%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Korsana Biosciences, Inc. Stock?
Korsana Biosciences (KRSA) appears to be a good buy right now due to its recent analyst upgrades and strong potential in the Alzheimer's treatment market. The stock is currently priced at $31.31, significantly below the analyst price targets of $70 and $44, indicating substantial upside potential. Furthermore, the gross margin stands at 100% for the upcoming quarters, reflecting the company's strong profitability potential once it begins generating revenue. However, the main risk is the projected net income loss of $3,177,000 in Q1 2026, which highlights ongoing financial challenges.
KRSA stock price ended at $30.11 on Wednesday, after rising +0.13%
Korsana Biosciences, Inc. (KRSA) last closed at $30.1100006, gaining +0.13%. These facts feed the 1-day and 1-week KRSA price prediction above.
Forecast Drivers
Korsana Biosciences, Inc. (KRSA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Seasonality analysis for KRSA
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.